|
|
 |
 |
|
|
|
|
|
|
 |
 |
 |
 |
|
|
|
|
 |
 |
| |
|
The controlled release of a pharmaceutical active can be a vital tool in ensuring the safety and efficacy of a new or existing treatment. Developing new methods of controlled release is important to prolong the duration of action, can help to minimise adverse reactions and maximise efficacy as well as being an effective way of increasing a drug's lifespan.
SMi's 7th Controlled Release conference will provide you with the latest updates in this area, including controlled release development strategies, practical issues in developing controlled release therapeutics and information on the latest advances in delivery methods.
|
 |
 |
Key topics to be addressed at the conference include:
- The application of advanced science & technology to develop controlled release dosage forms
- Controlled Release - the role of intellectual property in maintaining and growing market share
- Controlled release in chronic diseases
- Overcoming the blood brain barrier
- Modified release multiparticulates
- Hot melt extrusion: How to enhance dissolution rate by solid dispersions
- Developing novel inhaled controlled release therapeutics
|

|
Feedback from previous delegates includes:
"Very good - Good programme, good venue. A very successful meeting." Senior Representative, IPSEN
"Good balanced panel of speakers" Senior Rep, ESTEVE
"SMi conferences are always well organised and good topics for discussion" Senior Rep, Genzyme
This two day conference will allow you to:
- Identify opportunities for portfolio development
- Discover new strategies for developing controlled release products
- Hear from some of the leading organisations in the field
- Network and transfer knowledge with fellow senior drug development experts
- Establish relationships with new clients and suppliers
- Assess your activities against those leading the way
|
 |
This event will be chaired by:
 |
Dr Ian Wilding, Special Professor, School of Pharmacy, Nottingham University & President, Ian Wilding Associates Limited |
 |
Professor Howard Stevens, Emeritus Professor of Drug Delivery, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde |

- Dr Paul Ashton, President & Ceo, pSivida
- Professor Gregor Cevc, Chief Executive Officer, IDEA AG
- Alan Johnson, Partner, Bristows
- Dr Thomas Keller, Director - Biophysical Sensors & Nanomaterials PCD, GlaxoSmithKline
- Dr Vitaliy Khutoryanskiy, Lecturer in Pharmaceutics, University of Reading
- Dr Roger Kravtzoff, Director of Clinical and Preclinical Development, Flamel Technologies
- Dr Andrew Lewis, Operations Director, Critical Pharmaceuticals
- Dr Mario Maio, Head of Formulation and Process Development, Merck
- Dr Hassan Mohammad, Principal Scientist, Mundipharma International
- Gerben Moolhuizen, Chief Business Officer, OctoPlus
- Dr Joseph P. Reo, Research Fellow, Schering Plough Consumer Healthcare
- Dr Andreas Schatzlein, Reader in Cancer Pharmacology, The School of Pharmacy, University of London
- Dr Peter Scholes, VP Pharmaceutical Sciences, Quotient Clinical Ltd
- Professor Howard Stevens, Emeritus Professor of Drug Delivery, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde
- Dr Jens Uhlemann, Head of Product Design & Nanotechnology, Bayer Technology Services
- Professor Ian Wilding, Professor, Institute of Pharmaceutical Sciences, Nottingham University & President, Ian Wilding Associates Limited
- Dr Katie Amssoms, Senior Scientist, Tibotec
- Dr Gurjit Bajwa, Principal Scientist, Pfizer
|
|

All those responsible for research, clinical development and business development of controlled release products, including:
- Heads of Drug Development
- Heads of Business Development
- Directors of Regulatory and Technical Affairs
- Directors of Product Development
- Directors of R&D
- Operations Directors
- Chief Scientific Officers
- Principal Scientists, Product Development
- VP, Technology Development
|
|
Organisations represented at our previous Controlled Release conference have included:
- Abbott GmbH & Co KG
- Akzo Nobel
- AstraZeneca
- BASF
- Baxter
- Bayer
- Bristol-Myers Squibb
- BTG plc
- Celltech
- Cephalon Inc
- Colorcon Ltd
|
- Ferring Pharmaceuticals
- Flamel Technologies
- Genzyme Pharmaceuticals
- Glaxo Smith Kline
- Merck Sharp & Dohme Ltd
- Napp Laboratories
- Nektar Therapeutics
- Novartis
- Sanofi-Aventis
- Teva Pharmaceutical
- UCB-Celltech
|

Crowne Plaza St James London
45-51 Buckingham Gate
London
SW1E 6AF
Tel: +44 (0) 207 834 6655
Fax: +44 (0) 207 834 6307
www.london.crowneplaza.com |
 |
 |
|
Crowne Plaza St James London is a traditional deluxe hotel right in the heart of the city, perfectly situated for all your business and leisure needs. In the heart of Westminster, it is just a stones throw away from Buckingham Palace, The Houses of Parliament, the London Eye and Victoria Station.
The hotel boasts three excellent restaurants. Bistro 51 with British and European cuisine, the Michelin Starred Indian restaurant Quilon serving south coastal Indian food and Bank Westminster with a modern British menu. A beautiful, award-winning, courtyard garden surrounds the Victorian buildings of the Crowne Plaza London St James - a peaceful oasis in the centre of London.
Nearest train stations:
• Victoria Station, 7 minutes’ walk
• Waterloo Station, 10 minutes by car
Underground stations
• St James’s Park, 5 minutes’ walk (District and Circle lines)
• Victoria Station, 7 minutes' walk (Victoria, District and Circle lines)
From St. James's Park Underground Station to the Hotel
Take the main St James’s Park exit and turn left into Petty France Street.
Continue Straight down for 200 yards and at the end turn left into Buckingham Gate
SMi discounted rates include Continental Breakfast & VAT
£ 205.63 / Standard room / night for single occupancy
£ 229.13 Executive room / night for single occupancy
Book your accommodation at SMi discounted rates by calling us on +44 (0)870 9090 713, sending a fax to +44 (0)870 9090 714 or emailing hotels@smi-online.co.uk.
|
|
|
 |
|
|
|
 |
 |
|
|
 |
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
|
 |
|
 |